The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 84.
279. lappuse
... later on . But if you have it in there by way of detailed statement , then I would introduce my proofs later on . You say , might not affidavits be used here to supplement ? Yes , by all means . The whole proof of your utility statement ...
... later on . But if you have it in there by way of detailed statement , then I would introduce my proofs later on . You say , might not affidavits be used here to supplement ? Yes , by all means . The whole proof of your utility statement ...
319. lappuse
... later application is called a continuation . If there is new subject matter in the later application , it is usually referred to as a continuation - in - part . If the disclosure is the same but part only of the claimed subject matter ...
... later application is called a continuation . If there is new subject matter in the later application , it is usually referred to as a continuation - in - part . If the disclosure is the same but part only of the claimed subject matter ...
431. lappuse
... later application doesn't refer to an earlier one , but the Examiner records the presence of the earlier one , is the older one later available to the public ( assuming that no patent ever issued on the earlier one ) ? Mr. Stone : In ...
... later application doesn't refer to an earlier one , but the Examiner records the presence of the earlier one , is the older one later available to the public ( assuming that no patent ever issued on the earlier one ) ? Mr. Stone : In ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention